Portal de Periódicos da CAPES

Treatment optimization with secukinumab 150 mg for moderate‐to‐severe psoriasis in clinical practice: a single‐center open‐label 52‐week study

2018; Wiley; Volume: 57; Issue: 5 Linguagem: Inglês

10.1111/ijd.13953

1365-4632

C. Muñoz‐Santos, J. Sola-Ortigosa, Antonio Guilabert,

Autoimmune Bullous Skin Diseases

International Journal of DermatologyVolume 57, Issue 5 p. 615-617 Correspondence Treatment optimization with secukinumab 150 mg for moderate-to-severe psoriasis in clinical practice: a single-center open-label 52-week study Carlos Muñoz-Santos MD, PhD, Carlos Muñoz-Santos MD, PhD carlosmunozsantos@gmail.com orcid.org/0000-0003-3721-8030 Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, SpainSearch for more papers by this authorJoaquín Sola-Ortigosa MD, Joaquín Sola-Ortigosa MD Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, SpainSearch for more papers by this authorAntonio Guilabert MD, PhD, Antonio Guilabert MD, PhD Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, SpainSearch for more papers by this author Carlos Muñoz-Santos MD, PhD, Carlos Muñoz-Santos MD, PhD carlosmunozsantos@gmail.com orcid.org/0000-0003-3721-8030 Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, SpainSearch for more papers by this authorJoaquín Sola-Ortigosa MD, Joaquín Sola-Ortigosa MD Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, SpainSearch for more papers by this authorAntonio Guilabert MD, PhD, Antonio Guilabert MD, PhD Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Hospital General de Granollers, Granollers, SpainSearch for more papers by this author First published: 16 February 2018 https://doi.org/10.1111/ijd.13953Citations: 4 Conflicts of interest: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume57, Issue5May 2018Pages 615-617 RelatedInformation